Similar articles

• Transrectal ultrasound in detecting prostate cancer compared with serum total prostate-specific antigen levels.

  Tamsel S, Killi R, Hekimgil M, Altay B, Soydan S, Demirpolat G. Tamsel S, et al. J Med Imaging Radiat Oncol. 2008 Feb;52(1):24-8. doi: 10.1111/j.1440-1673.2007.01906.x. J Med Imaging Radiat Oncol. 2008. PMID: 18373822
• Prostate-specific antigen and transrectal ultrasound of the prostate in detection of prostate cancer.

  Cooner WH. Cooner WH. Clin Invest Med. 1993 Dec;16(6):471-4. Clin Invest Med. 1993. PMID: 7516834 Review.
• Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen.

  Xiao LH, Chen PR, Gou ZP, Li YZ, Li M, Xiang LC, Feng P. Xiao LH, et al. Asian J Androl. 2017 Sep-Oct;19(5):586-590. doi: 10.4103/1008-682X.186884. Asian J Androl. 2017. PMID: 27586028 Free PMC article.
• Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.

  Quentin M, Blondin D, Arsov C, Schimmöller L, Hiester A, Godehardt E, Albers P, Antoch G, Rabenalt R. Quentin M, et al. J Urol. 2014 Nov;192(5):1374-9. doi: 10.1016/j.juro.2014.05.090. Epub 2014 May 24. J Urol. 2014. PMID: 24866597 Clinical Trial.
• Transrectal prostate biopsy.

  Ismail MT, Gomella LG. Ismail MT, et al. Urol Clin North Am. 2013 Nov;40(4):457-72. doi: 10.1016/j.ucl.2013.07.012. Epub 2013 Sep 11. Urol Clin North Am. 2013. PMID: 24182969 Review.